The Human Papillomavirus (HPV) vaccine has the potential to greatly reduce the incidence
of cervical cancer by protecting against HPV infections responsible for 70% of cervical …

Objective To explore Chinese women's perceptions of human papillomavirus (HPV)
vaccination and their intention to be vaccinated. Design A cross‐sectional community‐based …

Cervical cancer (CC) ranks as the eighth most prevalent malignancy in Saudi Arabian
women of all ages. This cross-sectional study intends to assess women's knowledge …

Methods: PubMed (MEDLINE), Scopus, Web of Science, and Cochrane Library electronic
databases were systematically searched from July 1, 2006, up to September 30, 2021. We …

BACKGROUND: Young women have poor awareness that human papillomavirus (HPV) can
cause both cervical cancer and genital warts, a sexually transmitted infection (STI). A newly …

Among the identified barriers to HPV vaccination is the concern that women may
compensate for their reduced susceptibility to cervical cancers by reducing cervical cancer …

Background Concerns have been raised that HPV-vaccination might affect women's cervical
screening behavior. We therefore investigated the association between opportunistic HPV …

Human papillomavirus (HPV) is the causative agent in cervical cancer and has been
implicated in a range of other malignancies. Preventative vaccines are now internationally …

Background The relationship between infection with high-risk strains of human
papillomavirus (HPV) and cervical cancer is transforming prevention through HPV …

Background Persistent infection with certain subtypes of human papillomavirus (HPV) is a
necessary cause of cervical cancer. Although two prophylactic vaccines have been licensed …